NYSE$SEM

Select Medical Holdings Corporation · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Announced results for its first quarter ended March 31, 2021 and the declaration of a cash dividend.

Select Medical Holdings Corporation reported a revenue increase of 9.3% to $1,546.5 million, with net income rising by 94.8% to $137.2 million and earnings per share increasing to $0.82 for the first quarter ended March 31, 2021.

  • Revenue increased 9.3% to $1,546.5 million compared to the same quarter prior year.
  • Net income increased 94.8% to $137.2 million compared to the same quarter prior year.
  • Earnings per common share increased to $0.82 compared to the same quarter prior year.
  • Adjusted EBITDA increased 37.9% to $258.3 million compared to the same quarter prior year.

Headline financials

Total Revenue

$1.55B

Previous: $1.41B+9.3%
EPS (adj)

$0.82

Previous: $0.37+121.6%
Free Cash Flow

$111M

Previous: $53.1M+108.1%
Net Income

$111M

Previous: $53.1M+108.1%
Operating Income

$202M

Previous: $129M+57.0%
Gross Profit

-$1.29B

Previous: -$1.2B-7.6%
Cash & Equivalents

$750M

Previous: $73.2M+925.5%
Total Assets

$7.92B

Previous: $7.12B+11.3%
Stock-Based Comp

$6.71M

Previous: $6.9M-2.8%

Revenue & EPS history

Select Medical · Revenue · Quarterly

$1.55B

Q1 2021+9.3%vs Q1 2020
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Select Medical · $1.05B total across 3 segments · Q1 2021

  • Critical Illness Recovery
    $595M+18.9%
  • Outpatient Rehabilitation
    $252M-1.3%
  • Rehabilitation Hospital
    $208M+14.2%

Forward guidance

Select Medical is updating its business outlook following the reporting of its first quarter 2021 results. Select Medical now expects revenue for the full year of 2021 to be in the range of $5.7 billion to $5.9 billion and Adjusted EBITDA for the full year of 2021 to be in the range of $870.0 million to $900.0 million. Select Medical now expects earnings per common share for the full year of 2021 to be in the range of $2.41 to $2.58.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

-0.3%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+0.5%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+18.8%

Q3 2018

Best reaction

-22.2%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+0.1%+0.7%
Q4 2025-6.5%-7.3%+1.1%
Q3 2025-5.8%-5.1%+9.1%
Q1 2025-22.2%-17.7%-16.2%
Q4 2024-7.2%-2.9%-13.1%
Q3 2024+9.4%+13.3%+19.3%
Q2 2024-14.0%-17.2%-9.3%
Q1 2024+12.3%+17.0%+23.5%
Q4 2023+6.7%+4.6%+7.7%
Q3 2023-1.2%-2.7%+3.9%
Q2 2023-1.3%-2.5%-4.3%
Q1 2023+4.8%-0.8%-2.8%
Q4 2022-7.8%-9.1%-17.6%
Q3 2022-6.5%-10.9%+0.9%
Q2 2022-4.1%-11.1%-14.7%
Q1 2022+0.9%-4.2%+10.6%
Q4 2021+1.1%+2.2%+3.5%
Q3 2021+2.4%-0.9%-18.4%
Q2 2021-3.3%-6.9%-7.7%
Q1 2021-2.5%-3.1%+4.9%
Q4 2020+10.5%+16.9%+20.5%
Q3 2020-1.7%+8.5%+15.4%
Q2 2020+13.1%+14.7%+21.2%
Q1 2020-15.3%-12.9%-6.3%
Q4 2019+8.9%-0.1%-55.6%
Q3 2019+5.7%+10.6%+22.9%
Q2 2019-5.8%-5.8%-3.1%
Q1 2019+1.7%+3.0%-1.3%
Q4 2018+0.1%-4.8%-10.1%
Q3 2018+18.8%+21.2%+16.9%
Q2 2018-5.0%-7.5%-6.6%
Q1 2018-4.4%-3.5%-2.9%
Q4 2017+11.2%+11.4%+7.8%
Q3 2017-7.8%-9.4%-6.5%
Q2 2017+8.6%+12.7%+18.7%
Q1 2017+5.9%+1.1%+3.7%
Q4 2016+9.6%+11.6%-3.1%
Q3 2016-8.2%-6.1%-1.2%
Q2 2016+10.6%+6.3%+9.3%
Q1 2016-4.5%
Q4 2015+10.9%
Q3 2015+5.0%
Q2 2015+0.1%
Q1 2015+0.0%
Q4 2014-5.2%
Q3 2014+11.3%
Q2 2014-12.4%
Q1 2014+0.5%
Q4 2013+1.7%
Q3 2013+1.1%
Q2 2013+1.3%
Q1 2013-2.5%
Q4 2012+4.0%
Q3 2012+10.0%
Q2 2012+9.1%
Q1 2011-3.2%
Q1 2012+1.1%
Q4 2009-0.4%
Q4 2011-0.4%
Q3 2010-2.4%
Q3 2011-2.4%
Q4 2010-15.8%
Q2 2010-15.8%
Q2 2011-15.8%
Q1 2010-7.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro